SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial